US Stock MarketDetailed Quotes
ACET Adicet Bio
- 1.680
- -0.130-7.18%
Close Apr 26 16:00 ET
- 1.721
- +0.041+2.46%
Post 19:30 ET
138.04MMarket Cap-507P/E (TTM)
1.825High1.660Low1.25MVolume1.810Open1.810Pre Close2.17MTurnover2.55%Turnover RatioLossP/E (Static)82.17MShares7.50052wk High0.81P/B82.50MFloat Cap1.10052wk Low--Dividend TTM49.10MShs Float214.348Historical High--Div YieldTTM9.12%Amplitude0.931Historical Low1.734Avg Price1Lot Size
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Profile
SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com
Company Executives
- Name
- Position
- Salary
- Chen Schor, M.B.A.
- Chief Executive Officer, President and Director
- 3.99M
- Don Healey
- Chief Technology Officer
- --
- Dr. Blake Aftab
- Chief Scientific Officer
- 2.48M
- Dr. Francesco Galimi, M.D.,PhD
- Chief Medical Officer
- 1.99M
- Nick Harvey
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 218.87K
- Dr. Aya Jakobovits, PhD
- Independent Director
- 183.87K
- Dr. Andrew Sinclair, PhD
- Independent Director
- 194.37K
- Katie Peng
- Independent Director
- --
- Steve Dubin, J.D.
- Independent Director
- 197.87K
- Dr. Jeffrey A. Chodakewitz, M.D.
- Independent Director
- 183.87K
- Dr. Michael Glen Kauffman, M.D.,PhD
- Independent Director
- 182.87K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg